On air · 1 of 3 networks
Forbes Books
- forbesbooks.com
- Media, Events & Publishing
- US
- 99 employees
Forbes Books’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 932. Watch Forbes Books with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 912 | Checked 28 Oct 2026 | See all 932 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 20 Oct 2026 | Collect them with the API → |
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 29 Oct 2026 | Collect them with the API → |
Forbes Books has 912 live LinkedIn ads. Its Facebook page had no active ads on 20 Oct 2026, and we recorded no Google ads on 29 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 14 Oct 2026
Consistently choosing excellence in routine trial execution is what delivers meaningful breakthroughs for patients. Forbes Books Author Gary Zammit explores why quality must be actively measured and improved at every stage of development. Aligning research teams around clear scientific questions ensures clinical protocols produce reliable, real-world data. Read the full article below:
- LINKEDIN · IMAGESince 14 Oct 2026
Settling for "good enough" in clinical trial quality erodes research outcomes and delays critical patient therapies. Forbes Books Author Gary Zammit addresses why clinical trial design must aim beyond minimum regulatory standards. In his article, Gary breaks down how getting the right team, maintaining focus, and adopting relentless quality disciplines transforms routine trial execution into breakthrough medicine. Read the full article here. ⤵️
- LINKEDIN · IMAGESince 28 Sept 2026
A clinical trial's safety signals and efficacy outcomes depend entirely on the characteristics of the patients enrolled. Forbes Books Author Gary Zammit examines how screening practices directly affect trial outcomes. When patient qualification relies heavily on self-reported symptoms rather than objective biomarkers, issues like patient misrepresentation and placebo response inflation can undermine study validity. Centralized reviews and precise criteria help ensure reliable data. Read the full story:
- LINKEDIN · IMAGESince 28 Sept 2026
Patient safety and scientific validity depend on well-designed trial eligibility criteria. Forbes Books Author Gary Zammit addresses the challenge of balancing strict criteria with real-world applicability in clinical trials. When protocol demands grow too restrictive or rely on subjective screening, data integrity risks like rater inflation and baseline distortion can compromise study results. Read the full article here:
- LINKEDIN · IMAGESince 20 Aug 2026
Better communication can mean fewer delays, faster problem-solving, and stronger clinical trial execution. Forbes Books author Gary Zammit explains how clear communication structures help research teams stay aligned, address issues early, and keep complex trials on track. Read more on Forbes:
- LINKEDIN · IMAGESince 20 Aug 2026
Keep clinical trials moving by getting the right information to the right people at the right time. Forbes Books author Gary Zammit shares how a strong communication plan can improve accountability, surface problems earlier, and support more effective trial execution. Read the full Forbes article:
6 of 932 adsSign up to see every Forbes Books ad, filter by format and date, and get alerts on new ones.
See all 932 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.